EPISODE · Nov 12, 2025 · 3 MIN
OCEAN Trial: Ablate Afib. Assess. Anticoagulate? 🌊
from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC
🌊 OCEAN Trial offers fresh insight into antithrombotic therapy after successful AF ablation. In 1284 patients followed for 3 years, event rates were remarkably low 🌟. Rivaroxaban did not show superiority over aspirin for preventing stroke, systemic embolism, or covert embolic events, while bleeding risk was higher with anticoagulation. 🧠 96% had no new infarcts on MRI at follow-up. Published in NEJM (2025) — a valuable contribution to nuanced AF post-ablation care.
NOW PLAYING
OCEAN Trial: Ablate Afib. Assess. Anticoagulate? 🌊
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m